| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| CSTLCastle Biosciences, Inc. | 1.19B | 40.75 | 65.73 | 51.09% | -3.56% | -2.62% | 3.07% | 0.06 |
| MYNZMainz Biomed B.V. | 10.78M | 1.19 | -0.05 | -0.17% | -24.92% | -6.63% | 0.54 | |
| BNRBurning Rock Biotech Limited | 301.02M | 33.32 | -0.99 | -4.02% | -22.48% | -22.06% | 0.09 | |
| MDXHMDxHealth S.A. | 190.56M | 3.71 | -3.20 | 28.29% | -40.43% | -345.31% | 4.05 | |
| PSNLPersonalis, Inc. | 853.41M | 9.61 | -7.01 | 15.15% | -106.92% | -43.1% | 0.22 | |
| EXASExact Sciences Corporation | 19.44B | 102.34 | -18.31 | 10.37% | -32.01% | -39.44% | 0.38% | 1.15 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 111.17M | 208.87M | 381.68M | 429.9M | 507.86M | 563.24M | 537.43M | 515.82M |
| Revenue Growth % | - | 0.88% | 0.83% | 0.13% | 0.18% | 0.11% | -0.05% | -0.04% |
| Cost of Goods Sold | 39.47M | 73.81M | 108.34M | 115.98M | 143.72M | 183.2M | 174.21M | 153.42M |
| COGS % of Revenue | 0.36% | 0.35% | 0.28% | 0.27% | 0.28% | 0.33% | 0.32% | 0.3% |
| Gross Profit | 71.7M | 135.06M | 273.33M | 313.92M | 364.15M | 380.04M | 363.23M | 362.4M |
| Gross Margin % | 0.64% | 0.65% | 0.72% | 0.73% | 0.72% | 0.67% | 0.68% | 0.7% |
| Gross Profit Growth % | - | 0.88% | 1.02% | 0.15% | 0.16% | 0.04% | -0.04% | -0% |
| Operating Expenses | 192.56M | 296.45M | 442.43M | 726.33M | 1.16B | 1.36B | 1.03B | 719.96M |
| OpEx % of Revenue | 1.73% | 1.42% | 1.16% | 1.69% | 2.29% | 2.42% | 1.92% | 1.4% |
| Selling, General & Admin | 143.54M | 191.16M | 285.49M | 462.39M | 793.35M | 938.58M | 685.53M | 452.54M |
| SG&A % of Revenue | 1.29% | 0.92% | 0.75% | 1.08% | 1.56% | 1.67% | 1.28% | 0.88% |
| Research & Development | 49.02M | 105.3M | 156.94M | 263.94M | 367.86M | 421.87M | 347.02M | 232.29M |
| R&D % of Revenue | 0.44% | 0.5% | 0.41% | 0.61% | 0.72% | 0.75% | 0.65% | 0.45% |
| Other Operating Expenses | -32K | -488K | 0 | 0 | 0 | 0 | 0 | 35.13M |
| Operating Income | -120.87M | -161.4M | -169.09M | -412.4M | -797.06M | -980.41M | -669.32M | -357.56M |
| Operating Margin % | -1.09% | -0.77% | -0.44% | -0.96% | -1.57% | -1.74% | -1.25% | -0.69% |
| Operating Income Growth % | - | -0.34% | -0.05% | -1.44% | -0.93% | -0.23% | 0.32% | 0.47% |
| EBITDA | -99.55M | -136.72M | -137.73M | -379.1M | -749.3M | -856.31M | -535.92M | -305.36M |
| EBITDA Margin % | -0.9% | -0.65% | -0.36% | -0.88% | -1.48% | -1.52% | -1% | -0.59% |
| EBITDA Growth % | - | -0.37% | -0.01% | -1.75% | -0.98% | -0.14% | 0.37% | 0.43% |
| D&A (Non-Cash Add-back) | 21.31M | 24.68M | 31.36M | 33.31M | 47.77M | 124.1M | 133.4M | 52.2M |
| EBIT | -120.87M | -159.55M | -160.17M | -406.57M | -794.26M | -980.41M | -651.3M | -322.43M |
| Net Interest Income | -9.86M | -16.61M | 2.17M | 5.4M | 1.92M | 9.46M | 17.96M | 12.21M |
| Interest Income | 0 | 1.34M | 11.16M | 6.07M | 3.46M | 9.46M | 17.96M | 12.21M |
| Interest Expense | 9.86M | 17.95M | 8.99M | 667K | 1.54M | 0 | 0 | 0 |
| Other Income/Expense | -10.41M | -16.1M | -64K | 5.17M | 1.27M | 11.16M | 18.02M | 16.82M |
| Pretax Income | -131.28M | -177.5M | -169.16M | -407.24M | -795.8M | -969.25M | -651.3M | -340.74M |
| Pretax Margin % | -1.18% | -0.85% | -0.44% | -0.95% | -1.57% | -1.72% | -1.21% | -0.66% |
| Income Tax | 0 | 0 | 0 | 0 | 899K | 1.99M | 2.39M | 5.88M |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1.02% |
| Net Income | -131.28M | -177.5M | -168.34M | -407.24M | -796.7M | -971.23M | -653.69M | -346.63M |
| Net Margin % | -1.18% | -0.85% | -0.44% | -0.95% | -1.57% | -1.72% | -1.22% | -0.67% |
| Net Income Growth % | - | -0.35% | 0.05% | -1.42% | -0.96% | -0.22% | 0.33% | 0.47% |
| Net Income (Continuing) | -131.28M | -177.5M | -169.16M | -407.24M | -796.7M | -971.23M | -653.69M | -346.63M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -102.02 | -103.82 | -142.30 | -68.76 | -76.45 | -93.47 | -63.84 | -33.67 |
| EPS Growth % | - | -0.02% | -0.37% | 0.52% | -0.11% | -0.22% | 0.32% | 0.47% |
| EPS (Basic) | -102.02 | -103.82 | -142.30 | -68.76 | -76.45 | -93.47 | -63.84 | -33.67 |
| Diluted Shares Outstanding | 1.81M | 2.24M | 2.35M | 6.86M | 10.42M | 10.39M | 10.24M | 10.29M |
| Basic Shares Outstanding | 1.29M | 1.71M | 1.19M | 5.92M | 10.42M | 10.39M | 10.24M | 10.29M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 298.93M | 292.99M | 706.79M | 2.52B | 1.82B | 1.26B | 884.1M | 776.62M |
| Cash & Short-Term Investments | 190M | 130.13M | 408.22M | 2.26B | 1.5B | 905.45M | 615.1M | 519.85M |
| Cash Only | 54.79M | 93.34M | 94.23M | 1.9B | 1.43B | 905.45M | 615.1M | 519.85M |
| Short-Term Investments | 135.21M | 36.79M | 313.99M | 362.13M | 63.76M | 0 | 0 | 0 |
| Accounts Receivable | 41.23M | 35.52M | 89.73M | 110.75M | 161.43M | 170.23M | 149.61M | 173.45M |
| Days Sales Outstanding | 135.38 | 62.07 | 85.81 | 94.03 | 116.02 | 110.32 | 101.61 | 122.73 |
| Inventory | 16.8M | 49.05M | 58.12M | 68.02M | 123.21M | 130.32M | 69.02M | 53.76M |
| Days Inventory Outstanding | 155.4 | 242.59 | 195.79 | 214.07 | 312.92 | 259.65 | 144.61 | 127.91 |
| Other Current Assets | 50.9M | 3.45M | 133.84M | 67.41M | 8.66M | 30.14M | 21.12M | 11.57M |
| Total Non-Current Assets | 101.4M | 79.69M | 140.77M | 139.38M | 457.64M | 328.7M | 155.91M | 108.69M |
| Property, Plant & Equipment | 60.69M | 69.58M | 89.31M | 111.48M | 406.44M | 300.03M | 144.2M | 100.34M |
| Fixed Asset Turnover | 1.83x | 3.00x | 4.27x | 3.86x | 1.25x | 1.88x | 3.73x | 5.14x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 1.82M | 0 | 0 |
| Intangible Assets | 516K | 482K | 343K | 3.46M | 5.15M | 161K | 964K | 421K |
| Long-Term Investments | 37.33M | 1.99M | 40.16M | 1.42M | 910K | 690K | 337K | 0 |
| Other Non-Current Assets | 2.86M | 7.63M | 10.95M | 23.02M | 45.14M | 26M | 10.41M | 7.93M |
| Total Assets | 400.33M | 372.67M | 847.56M | 2.66B | 2.28B | 1.59B | 1.04B | 885.3M |
| Asset Turnover | 0.28x | 0.56x | 0.45x | 0.16x | 0.22x | 0.35x | 0.52x | 0.58x |
| Asset Growth % | - | -0.07% | 1.27% | 2.14% | -0.14% | -0.3% | -0.34% | -0.15% |
| Total Current Liabilities | 78.06M | 284.7M | 164.44M | 241.53M | 372.18M | 411.45M | 263.36M | 266.3M |
| Accounts Payable | 0 | 16.27M | 12.35M | 35.48M | 63.08M | 50.95M | 18.06M | 33.75M |
| Days Payables Outstanding | - | 80.44 | 41.6 | 111.66 | 160.21 | 101.51 | 37.84 | 80.29 |
| Short-Term Debt | 14.88M | 176.27M | 39.5M | 42.06M | 2.37M | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 48.92M | 3.13M | 3.08M | 4.76M | 13.17M | 58.58M | 18.95M | 18.1M |
| Current Ratio | 3.83x | 1.03x | 4.30x | 10.45x | 4.89x | 3.06x | 3.36x | 2.92x |
| Quick Ratio | 3.61x | 0.86x | 3.94x | 10.17x | 4.56x | 2.74x | 3.09x | 2.71x |
| Cash Conversion Cycle | - | 224.22 | 240 | 196.43 | 268.73 | 268.46 | 208.37 | 170.35 |
| Total Non-Current Liabilities | 153.79M | 691.44M | 1.57B | 491K | 61.09M | 17.68M | 8.23M | 38.18M |
| Long-Term Debt | 153.79M | 87.64M | 18.27M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 5.69M | 4.82M | 0 | 49.32M | 13.55M | 3.69M | 27.75M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 596.12M | 1.55B | 228K | 11.78M | 4.12M | 4.54M | 10.43M |
| Total Liabilities | 231.85M | 976.14M | 1.74B | 242.02M | 433.28M | 429.13M | 271.59M | 304.48M |
| Total Debt | 168.67M | 272.27M | 67.47M | 46.88M | 86.69M | 50.79M | 12.32M | 52.32M |
| Net Debt | 113.88M | 178.93M | -26.76M | -1.85B | -1.34B | -854.66M | -602.77M | -467.53M |
| Debt / Equity | 1.00x | - | - | 0.02x | 0.05x | 0.04x | 0.02x | 0.09x |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | -12.26x | -8.99x | -18.81x | -618.30x | -518.92x | - | - | - |
| Total Equity | 168.49M | -603.46M | -891.49M | 2.42B | 1.85B | 1.16B | 768.41M | 580.83M |
| Equity Growth % | - | -4.58% | -0.48% | 3.72% | -0.24% | -0.37% | -0.34% | -0.24% |
| Book Value per Share | 93.14 | -269.66 | -379.62 | 352.74 | 177.08 | 111.48 | 75.04 | 56.43 |
| Total Shareholders' Equity | 168.49M | -603.46M | -891.49M | 2.42B | 1.85B | 1.16B | 768.41M | 580.83M |
| Common Stock | 28K | 29K | 31K | 137K | 137K | 138K | 137K | 145K |
| Retained Earnings | -379.52M | -612M | -946.46M | -1.42B | -2.23B | -3.2B | -3.85B | -4.2B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | -58.92M | -65.9M | -63.26M |
| Accumulated OCI | -10.88M | -14.8M | 9.3M | -167.59M | -207.07M | -165.72M | -161.53M | -158.05M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -133.7M | -148.78M | -228.04M | -73.54M | -477.89M | -456.81M | -255.78M | -92.26M |
| Operating CF Margin % | -1.2% | -0.71% | -0.6% | -0.17% | -0.94% | -0.81% | -0.48% | -0.18% |
| Operating CF Growth % | - | -0.11% | -0.53% | 0.68% | -5.5% | 0.04% | 0.44% | 0.64% |
| Net Income | -131.28M | -177.5M | -169.16M | -407.24M | -796.7M | -971.23M | -653.69M | -346.63M |
| Depreciation & Amortization | 21.31M | 24.68M | 31.36M | 33.31M | 47.77M | 124.1M | 133.4M | 52.2M |
| Stock-Based Compensation | 4.05M | 5.09M | 22.79M | 173.22M | 282.43M | 326.78M | 260.72M | 155.62M |
| Deferred Taxes | 1.16M | 1.37M | 15.62M | 0 | 15.39M | 0 | 0 | 0 |
| Other Non-Cash Items | 5.84M | 3.74M | 1.81M | 15.07M | 35.61M | 74.7M | 55.94M | 83.08M |
| Working Capital Changes | -34.79M | -6.16M | -130.46M | 112.1M | -62.4M | -11.16M | -52.16M | -36.53M |
| Change in Receivables | -31.16M | 4.16M | -65.95M | -13.04M | -18.93M | -42.16M | -12.39M | -26.8M |
| Change in Inventory | -489K | -32.25M | -8.12M | -9.44M | -67M | -21.65M | 57.28M | 2.51M |
| Change in Payables | 9.57M | 2.2M | -3.32M | 25.84M | -5.1M | 16.63M | -31.12M | 18.89M |
| Cash from Investing | -191.08M | 106.09M | -346.66M | -109.31M | 81.7M | -7.46M | -9.3M | -4.41M |
| Capital Expenditures | -23.01M | -24.71M | -45.73M | -79.54M | -213.45M | -62.03M | -8.1M | -5.42M |
| CapEx % of Revenue | 0.21% | 0.12% | 0.12% | 0.19% | 0.42% | 0.11% | 0.02% | 0.01% |
| Acquisitions | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | -557K | 122K | -303K | -3.32M | -1.96M | -11.03M | -1.2M | 1.01M |
| Cash from Financing | 354.17M | 83.39M | 571.74M | 2.17B | -52.9M | -86.24M | -48.83M | -72K |
| Debt Issued (Net) | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - |
| Other Financing | 0 | 0 | 0 | 67.96M | -3.82M | -12.03M | -41.85M | 0 |
| Net Change in Cash | - | - | - | - | - | - | - | - |
| Free Cash Flow | -156.72M | -173.5M | -273.77M | -153.08M | -691.33M | -518.84M | -265.17M | -98.24M |
| FCF Margin % | -1.41% | -0.83% | -0.72% | -0.36% | -1.36% | -0.92% | -0.49% | -0.19% |
| FCF Growth % | - | -0.11% | -0.58% | 0.44% | -3.52% | 0.25% | 0.49% | 0.63% |
| FCF per Share | -86.64 | -77.53 | -116.58 | -22.30 | -66.34 | -49.93 | -25.90 | -9.54 |
| FCF Conversion (FCF/Net Income) | 1.02x | 0.84x | 1.35x | 0.18x | 0.60x | 0.47x | 0.39x | 0.27x |
| Interest Paid | 0 | 0 | 0 | 0 | 1.52M | 877K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 1.1M | 98K | 0 | 0 |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -77.91% | - | - | -53.25% | -37.35% | -64.67% | -67.85% | -51.38% |
| Return on Invested Capital (ROIC) | - | - | - | - | -111.4% | -182.83% | -213.92% | -192.28% |
| Gross Margin | 64.49% | 64.66% | 71.61% | 73.02% | 71.7% | 67.47% | 67.59% | 70.26% |
| Net Margin | -118.09% | -84.98% | -44.1% | -94.73% | -156.87% | -172.44% | -121.63% | -67.2% |
| Debt / Equity | 1.00x | - | - | 0.02x | 0.05x | 0.04x | 0.02x | 0.09x |
| Interest Coverage | -12.26x | -8.99x | -18.81x | -618.30x | -518.92x | - | - | - |
| FCF Conversion | 1.02x | 0.84x | 1.35x | 0.18x | 0.60x | 0.47x | 0.39x | 0.27x |
| Revenue Growth | - | 87.89% | 82.74% | 12.64% | 18.13% | 10.9% | -4.58% | -4.02% |
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Service | 391.32M | 435.87M | 511.45M | 345.03M | 290.74M |
| Service Growth | - | 11.38% | 17.34% | -32.54% | -15.74% |
| Product | 154.57M | 215.71M | 234.99M | 192.41M | 225.08M |
| Product Growth | - | 39.56% | 8.94% | -18.12% | 16.98% |
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| CHINA | - | - | 553.3M | 534.93M | 510.24M |
| CHINA Growth | - | - | - | -3.32% | -4.62% |
| UNITED STATES | - | - | - | 2.51M | 5.58M |
| UNITED STATES Growth | - | - | - | - | 122.62% |
Burning Rock Biotech Limited (BNR) reported $539.3M in revenue for fiscal year 2024. This represents a 385% increase from $111.2M in 2017.
Burning Rock Biotech Limited (BNR) saw revenue decline by 4.0% over the past year.
Burning Rock Biotech Limited (BNR) reported a net loss of $121.3M for fiscal year 2024.
Burning Rock Biotech Limited (BNR) has a return on equity (ROE) of -51.4%. Negative ROE indicates the company is unprofitable.
Burning Rock Biotech Limited (BNR) had negative free cash flow of $37.8M in fiscal year 2024, likely due to heavy capital investments.